AngioDynamics (ANGO) Cash Flow: Operating & Free Cash Flow

AngioDynamics Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for AngioDynamics, Inc. (ANGO) - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	May 2026	May 2025	May 2024	May 2023	May 2022	May 2021	May 2020	May 2019	May 2018	May 2017
Operating Activities
Net Income	-36.74	-33.99	-184.35	-52.44	-26.55	-31.55	-156.07	61.34	16.34	7.01
Depreciation & Amortization	22.96	25.80	27.71	30.87	29.35	25.92	23.81	25.88	23.16	24.81
Deferred Income Tax	0.14	-0.99	-7.97	-2.31	-3.71	-4.81	-1.57	-2.66	-8.95	4.43
Stock Based Compensation	13.96	9.77	10.53	11.16	10.69	8.63	7.59	9.25	7.91	6.18
Change in Working Capital	-2.66	-14.11	14.42	-7.03	-21.05	9.07	-28.55	-1.26	2.46	24.86
Change in Accounts Receivable	-5.75	0.02	7.89	-1.30	-17.15	-4.16	11.92	-3.18	5.04	8.48
Change in Inventory	10.05	-1.35	-9.41	-8.20	-2.80	11.54	-18.85	-1.43	5.74	0.69
Change in Accounts Payable	-5.83	-15.88	27.53	2.14	3.91	4.88	-15.47	5.21	-7.09	17.21
Change in Other Working Capital	3.81	3.09	-11.59	0.33	-5.01	-3.18	-6.16	-1.87	-1.23	-3.52
Other Operating Activities	3.81	3.39	111.50	17.52	4.07	12.03	140.23	-55.11	0.36	-9.55
Net Cash from Operating Activities	3.09	-10.13	-28.16	0.08	-7.19	24.09	-14.55	37.44	41.29	55.75
Investing Activities
Capital Expenditures	-2.58	-4.46	-5.77	-3.81	-4.30	-13.71	-7.59	-3.12	-3.66	-3.00
Acquisitions	0.00	0.00	0.00	0.00	-3.60	0.00	-55.76	-84.92	0.00	0.00
Purchases of Investments	0.00	0.00	0.00	-5.39	0.00	0.00	0.00	0.00	0.00	0.00
Sales/Maturities of Investments	0.00	0.00	0.00	-0.54	0.00	0.00	0.00	1.35	0.00	0.45
Other Investing Activities	-3.37	-5.71	126.24	-5.93	-11.41	-8.52	-0.35	169.24	-1.27	0.00
Net Cash from Investing Activities	-5.95	-10.18	123.72	-9.75	-19.31	-13.71	-63.35	82.55	-3.66	-2.55
Financing Activities
Debt Repayment	-0.38	6.16	-50.00	-45.00	5.00	-20.00	-92.50	40.00	-5.00	-23.91
Common Stock Issued	0.94	0.00	0.75	1.17	2.68	3.01	0.00	0.00	0.00	0.00
Common Stock Repurchased	0.00	-1.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-13.56
Other Financing Activities	-0.38	-4.75	-15.00	-0.75	0.00	0.00	-2.74	-6.07	-6.55	-0.52
Net Cash from Financing Activities	0.56	-0.26	-64.25	25.42	7.68	-16.99	-95.24	33.93	-11.55	-37.98
Summary
Effect of Forex Changes on Cash	0.27	0.40	0.13	0.04	-0.52	0.33	-0.07	-0.38	0.47	0.00
Net Change in Cash	-2.03	-20.16	31.44	15.80	-19.34	-6.27	-173.21	153.55	26.55	15.21
Cash at Beginning of Period	55.89	76.06	44.62	28.83	48.16	54.44	227.64	74.10	47.54	32.33
Cash at End of Period	53.86	55.89	76.06	44.62	28.83	48.16	54.44	227.64	74.10	47.54
Free Cash Flow	0.51	-14.59	-33.93	-3.73	-11.49	10.38	-22.14	34.32	37.63	52.74
Supplemental Disclosures
Interest Paid	-	0.19	-	2.58	0.56	0.73	-	-	-	-
Income Taxes Paid	-	0.80	0.46	0.34	0.33	0.31	-	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Aug 31, 2026. Data sources and methodology

Frequently Asked Questions About AngioDynamics Cash Flow

What is AngioDynamics's free cash flow?

AngioDynamics generated free cash flow of $508.00K in fiscal 2026 (fiscal year ended May 31, 2026), operating cash flow of $3.09M minus $2.58M of capital expenditures. Free cash flow equaled 0.2% of revenue.

How much does AngioDynamics spend on capital expenditures?

AngioDynamics spent $2.58M on capital expenditures in fiscal 2026, compared with $4.46M a year earlier. That equals 83.6% of operating cash flow.

Does AngioDynamics pay dividends or buy back shares?

AngioDynamics's cash flow statement for fiscal 2026 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition